| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, SUITE 1700, NEW YORK | /s/ Adam C. Vandervoort | 03 Mar 2026 | 0001375088 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TDOC | Common Stock | Options Exercise | +4,418 | +5.5% | 85,150 | 27 Feb 2026 | Direct | F1 | ||
| transaction | TDOC | Common Stock | Options Exercise | +5,350 | +6.3% | 90,500 | 27 Feb 2026 | Direct | F1 | ||
| transaction | TDOC | Common Stock | Options Exercise | +36,610 | +40% | 127,110 | 27 Feb 2026 | Direct | F1 | ||
| transaction | TDOC | Common Stock | Options Exercise | +1,510 | +1.2% | 128,620 | 27 Feb 2026 | Direct | F2 | ||
| transaction | TDOC | Common Stock | Options Exercise | +1,702 | +1.3% | 130,322 | 27 Feb 2026 | Direct | F2 | ||
| transaction | TDOC | Common Stock | Sale | $138,584 | -27,083 | -21% | $5.12 | 103,239 | 02 Mar 2026 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TDOC | Restricted Stock Units | Options Exercise | $0 | -4,418 | -100% | $0.000000 | 0 | 27 Feb 2026 | Common Stock | 4,418 | Direct | F1, F4 | |
| transaction | TDOC | Restricted Stock Units | Options Exercise | $0 | -5,350 | -20% | $0.000000 | 21,400 | 27 Feb 2026 | Common Stock | 5,350 | Direct | F1, F5 | |
| transaction | TDOC | Restricted Stock Units | Options Exercise | $0 | -36,610 | -33% | $0.000000 | 73,222 | 27 Feb 2026 | Common Stock | 36,610 | Direct | F1, F6 | |
| transaction | TDOC | Performance Stock Units | Options Exercise | $0 | -1,510 | -100% | $0.000000 | 0 | 27 Feb 2026 | Common Stock | 1,510 | Direct | F2, F7 | |
| transaction | TDOC | Performance Stock Units | Award | $0 | +5,107 | $0.000000 | 5,107 | 27 Feb 2026 | Common Stock | 5,107 | Direct | F8, F9, F10 | ||
| transaction | TDOC | Performance Stock Units | Options Exercise | $0 | -1,702 | -33% | $0.000000 | 3,405 | 27 Feb 2026 | Common Stock | 1,702 | Direct | F2, F11 | |
| transaction | TDOC | Restricted Stock Units | Award | $0 | +181,661 | $0.000000 | 181,661 | 01 Mar 2026 | Common Stock | 181,661 | Direct | F12, F13 |
| Id | Content |
|---|---|
| F1 | Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| F2 | Performance stock units convert to shares of TDOC common stock on a one-for-one basis. |
| F3 | Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| F4 | On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| F5 | On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on March 19, 2025, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
| F6 | On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| F7 | On March 1, 2024, the reporting person earned 18,067 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| F8 | Each performance stock unit represents a contingent right to receive one share of TDOC common stock. |
| F9 | Performance award amount determined based on metrics in respect of the issuer's 2025 financial results. |
| F10 | The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| F11 | On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| F12 | Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. |
| F13 | One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |